An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study

por Sen, Arjune, Akinola, Mary, Tai, Xin You, Symmonds, Mkael, Davis Jones, Gabriel, Mura, Sergio, Galloway, Joanne, Hallam, Angela, Chan, Jane Y. C., Koychev, Ivan, Butler, Chris, Geddes, John, Van Der Putt, Rohan, Thompson, Sian, Manohar, Sanjay G., Frangou, Eleni, Love, Sharon, McShane, Rupert, Husain, Masud
Publicado 2021